2-((4-Ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid

Catalog No. :
ACUXCV275
CAS No. :
537016-62-9
Molecular Formula :
C10H11N3O3S
Molecular Weight :
253.28

IUPAC Name:2-((4-ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid

2-((4-Ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$84.00Login to see priceInquiryInquiry
100mg97%$121.00Login to see priceInquiryInquiry
250mg97%$163.00Login to see priceInquiryInquiry
1g97%$410.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
IUPAC Name2-((4-ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
MDL No.MFCD02596624
Molecular FormulaC10H11N3O3S
Molecular Weight253.28
SMILESO=C(O)CSC1=NN=C(C2=CC=CO2)N1CC
InChI KeyXKDQSHRGTJXAJN-UHFFFAOYSA-N
Synonym(4-ETHYL-5-FURAN-2-YL-4 H-[1,2,4]TRIAZOL-3-YLSULFANYL)-ACETIC ACID;[[4-ETHYL-5-(2-FURYL)-4H-1,2,4-TRIAZOL-3-YL]THIO]ACETIC ACID;Acetic acid, 2-[[4-ethyl-5-(2-furanyl)-4H-1,2,4-triazol-3-yl]thio]-;2-{[4-Ethyl-5-(furan-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic Acid
CAS No.537016-62-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACUXCV275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUXCV275 route product structure diagram
    ACUXCV275537016-62-9
Inquiry

2. ACUXCV275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUXCV275 route product structure diagram
    ACUXCV275537016-62-9
Inquiry

Comments (0)